Harber Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-489
Closed -$3.08M 32
2020
Q4
$3.08M Sell
489
-250
-34% -$24K 0.84% 30
2020
Q3
$2.72M Buy
739
+7
+1% +$659 0.75% 30
2020
Q2
$2.27M Hold
732
0.59% 30
2020
Q1
$985K Hold
732
0.26% 33
2019
Q4
$1.57M Buy
+732
New +$60.8K 0.37% 40
2019
Q3
Sell
-732
Closed -$717K 39
2019
Q2
$717K Buy
+732
New +$57.5K 0.2% 37

Other funds holding ABBV

Harber Asset Management's ABBV Position: Q1 2020 in Review

Harber Asset Management sold out of AbbVie (ABBV) in Q1 2020, closing a stake of 30,652 shares — an estimated $2.61M sold.

Harber Asset Management first reported a position in ABBV in Q3 2019 and held it in 2 quarters. The position peaked at $2.71M in Q4 2019. 2,225 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

  • Harber Asset Management reported no remaining AbbVie position as of Q1 2020 after selling out during the quarter.
  • Harber Asset Management sold 30,652 AbbVie shares in Q1 2020, an estimated $2.61M.
  • Harber Asset Management first reported a position in AbbVie in Q3 2019 and held it in 2 quarters.
  • Harber Asset Management's AbbVie position peaked at $2.71M in Q4 2019.
  • 2,225 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on Harber Asset Management's 13F filing for Q1 2020, filed 15 May 2020.